ZINZINO AB (PUBL): PRELIMINARY SALES REPORT 2023

GOTHENBURG, Sweden, Jan. 5, 2024 /PRNewswire/ — Zinzino group total revenue increased 23% in Q4 and total revenue for the full year 2023 increased 23%, compared to the previous year.

The revenue in December for Zinzino’s sales markets increased by 23 % and amounted to SEK 152.4 (123.8) million. Faun Pharma’s external sales decreased and amounted to SEK 5.0 (5.1) million. Overall, the Group increased revenues by 22% to SEK 157.4 (128.9) million compared with the previous year.

Sales in Zinzino’s sales markets increased by 24% in the fourth quarter of 2023 compared with the same period last year and amounted to SEK 511.2 (413.3) million. Total revenues in the Group increased by 23 % in the fourth quarter and amounted to SEK 529.8 (429.3) million.

Accumulated revenue for January – December 2023 increased by 23% to SEK 1768.3 (1443.1) million.

Revenues were distributed as follows:

Countries in regions:
-The Nordics: Denmark, Faroe Island, Finland, Iceland, Norway, Sweden
–Central Europe: Austria, Germany, Switzerland
–East Europe: Czech Republic, Slovakia, Hungary, Poland, Romania
-South & West Europe: Cyprus, France, Greece, Italy, Luxembourg, Malta, Netherlands, Slovenia, Spain, United Kingdom, Belgium, Ireland, Turkey
-The Baltics: Estonia, Latvia, Lithuania
–North America: Canada, USA, Mexico
–Asia-Pacific: Australia, Hong Kong, India, Malaysia, Singapore, Taiwan, Thailand
–Africa: South Africa

For more information:
Dag Bergheim Pettersen CEO Zinzino +47 (0) 932 25 700, zinzino.com 

Pictures for publication free of charge:
[email protected] 

Certified Adviser:
Carnegie Investment Bank AB (publ)

The following files are available for download:

View original content:https://www.prnewswire.co.uk/news-releases/zinzino-ab-publ-preliminary-sales-report-2023-302027063.html